Canterbury DHB


Recombinant Factor VIII

Recombinant Factor VIII is available as either short half-life (Advate) or extended half-life (Adynovate), the Pharmac-reimbursed brands.

Current usage of recombinant products for factor VIII includes:

In This Section


Adynovate (extended half-life rFVIII)


Adynovate (extended half-life rFVIII)

About this Canterbury DHB document (5290):

Document Owner:

Sean Macpherson (see Who's Who)

Last Reviewed:

November 2019

Next Review:

November 2022


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5290